Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study

Shinji Ohno, Hirofumi Mukai, Kazutaka Narui, Yasuo Hozumi, Yasuo Miyoshi, Hiroshi Yoshino, Hiroyoshi Doihara, Akihiko Suto, Motoshi Tamura, Takashi Morimoto, Hisamitsu Zaha, Takashi Chishima, Reiki Nishimura, Takashi Ishikawa, Yukari Uemura, Yasuo Ohashi

Research output: Contribution to journalArticle

Abstract

Purpose: While some studies show improved outcomes in clinical trial participants as compared to non-participants, existence of such a trial effect has not been proved precisely. Methods: This was a prospective cohort study to compare the prognoses for participants in the randomized controlled trial (SELECT BC) and non-participants. SELECT BC compared S-1 and taxane as first-line treatment for metastatic breast cancer. Non-participants were all patients who met the eligibility criteria of SELECT BC and who had been requested to participate in that trial by attending doctors and declined. The study aimed to compare the prognoses between participants and non-participants. The primary endpoint was median overall survival. Results: The median OS in participants was significantly superior to that in non-participants with a statistically significant difference (36.8 months vs. 25.2 months. HR 1.48, p = 0.022). A similar result was obtained when only patients who received the same chemotherapy (S-1 or taxane) used in SELECT BC after declining participation were assumed as non-participants (36.8 months vs. 22.0 months. HR 2.03, p = 0.006). Conclusions: This study may suggest the existence of a trial effect, in which, for a given treatment, participation in a clinical trial is associated with a better outcome.

Original languageEnglish
Pages (from-to)631-635
Number of pages5
JournalBreast Cancer Research and Treatment
Volume176
Issue number3
DOIs
Publication statusPublished - Aug 15 2019
Externally publishedYes

Keywords

  • Overall survival
  • Prospective cohort study
  • Randomized control trial
  • SELECT BC
  • Trial effect

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study'. Together they form a unique fingerprint.

  • Cite this

    Ohno, S., Mukai, H., Narui, K., Hozumi, Y., Miyoshi, Y., Yoshino, H., Doihara, H., Suto, A., Tamura, M., Morimoto, T., Zaha, H., Chishima, T., Nishimura, R., Ishikawa, T., Uemura, Y., & Ohashi, Y. (2019). Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study. Breast Cancer Research and Treatment, 176(3), 631-635. https://doi.org/10.1007/s10549-019-05276-y